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A B S T R A C T
This study describes the ﬁrst multiway comparison of portable isothermal assays for the detection of foot-and-
mouth disease virus (FMDV), benchmarked against real-time reverse transcription RT-PCR (rRT-PCR). The se-
lected isothermal chemistries included reverse transcription loop-mediated isothermal ampliﬁcation (RT-LAMP)
and reverse transcription recombinase polymerase ampliﬁcation (RT-RPA). The analytical sensitivity of RT-
LAMP was comparable to rRT-PCR (101 RNA copies), while RT-RPA was one log10 less sensitive (102 RNA
copies). Diagnostic performance was evaluated using a panel of 35 samples from FMDV-positive cattle and eight
samples from cattle infected with other vesicular viruses. Assay concordance for RT-LAMP and RT-RPA was
86–98% and 67–77%, respectively, when compared to rRT-PCR, with discordant samples consistently having
high rRT-PCR cycle threshold values (no false-positives were detected for any assay). In addition, a hierarchy of
sample preparation methods, from robotic extraction to simple dilution of samples, for epithelial suspensions,
serum and oesophageal-pharyngeal (OP) ﬂuid were evaluated. Results obtained for RT-LAMP conﬁrmed that
FMDV RNA can be detected in the absence of RNA extraction. However, simple sample preparation methods
were less encouraging for RT-RPA, with accurate results only obtained when using RNA extraction. Although the
evaluation of assay performance is speciﬁc to the conditions tested in this study, the compatibility of RT-LAMP
chemistry with multiple sample types, both in the presence and absence of nucleic acid extraction, provides
advantages over alternative isothermal chemistries and alternative pen-side diagnostics such as antigen-detec-
tion lateral-ﬂow devices. These characteristics of RT-LAMP enable the assay to be performed over a large di-
agnostic detection window, providing a realistic means to rapidly conﬁrm positive FMD cases close to the point
of sampling.
1. Introduction
Molecular diagnostic assays such as PCR are now recognised as re-
liable detection methods for many viral pathogens, including foot-and-
mouth disease (FMD) virus (FMDV: family Picornaviridae, genus
Aphthovirus) (The World Organisation for Animal Health [OIE, (2012)],
2012). Endemic across many countries in Asia and Africa and parts of
South America, FMD is highly contagious, with outbreaks in previously
disease-free areas incurring severe economic damage (Knight-Jones and
Rushton, 2013). Accurate and early diagnosis is therefore critical for
the rapid enforcement of monitoring, control and eradication strategies.
Laboratory-based real-time reverse transcription PCR (rRT-PCR) has
become a widely accepted molecular tool for the detection and quan-
tiﬁcation of FMDV RNA, with diagnostic rRT-PCR assays developed for
detection of all seven FMDV serotypes (A, O, C, Asia 1 and Southern
African Territories [SAT] types 1–3) across a wide range of sample
types (Callahan et al., 2002; Reid et al., 2002). Although relatively
quick to perform, only taking a few hours to produce results (Shaw
et al., 2007), sample transportation to laboratories is required which
can be lengthy and consequently delay critical decision making.
http://dx.doi.org/10.1016/j.jviromet.2017.08.013
Received 25 May 2017; Received in revised form 18 July 2017; Accepted 16 August 2017
⁎ Corresponding author at: The Pirbright Institute, Ash Road, Pirbright, Surrey, GU24 0NF, UK.
E-mail addresses: emma.howson@pirbright.ac.uk (E.L.A. Howson), ykuro@nagasaki-u.ac.jp (Y. Kurosaki), j-yasuda@nagasaki-u.ac.jp (J. Yasuda),
masayoshi8.takahashi@toshiba.co.jp (M. Takahashi), hiroaki.goto@toshiba.co.jp (H. Goto), ashley.gray@pirbright.ac.uk (A.R. Gray), valerie.mioulet@pirbright.ac.uk (V. Mioulet),
donald.king@pirbright.ac.uk (D.P. King), veronica.fowler@pirbright.ac.uk (V.L. Fowler).
Journal of Virological Methods 249 (2017) 102–110
Available online 31 August 2017
0166-0934/ © 2017 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY license (http://creativecommons.org/licenses/BY/4.0/).
MARK
In order to address this gap, research initiatives have prioritised the
transition of molecular assays into formats suitable for deployment
closer to suspect cases of FMD. For instance, rRT-PCR has been trans-
ferred onto a portable platform which integrates RNA extraction,
thermal cycling and result reporting (Madi et al., 2012), and trialled
successfully in ﬁeld settings (Howson et al., 2015). However, in order to
maintain precise thermal regulation for PCR, expensive instrumentation
is necessary. As an alternative, a number of isothermal chemistries have
been adapted for detection of FMDV. To date, there are 17 FMDV-
speciﬁc publications detailing four isothermal chemistries: reverse
transcription loop-mediated isothermal ampliﬁcation ([RT-LAMP]
Dukes et al., 2006; Li et al., 2009; Ranjan et al., 2014; Shao et al., 2010;
Chen et al., 2011a,2011b; Yamazaki et al., 2013; Madhanmohan et al.,
2013; Guan et al., 2013; Waters et al., 2014; Ding et al., 2014; Howson
et al., 2015), reverse transcription recombinase polymerase ampliﬁca-
tion ([RT-RPA] Abd El Wahed et al., 2013), nucleic acid sequence based
ampliﬁcation ([NASBA] Collins et al., 2002; Lau et al., 2006; Lau et al.,
2007) and reverse transcription helicase dependent ampliﬁcation ([RT-
HDA] Jingwei et al., 2014; Jing et al., 2013). Two of these (RT-LAMP
and RT-RPA) have been transitioned into portable formats and suc-
cessfully trialled in endemic settings (Abd El Wahed et al., 2013;
Howson et al., 2015).
Understanding the diagnostic performance of new and improved
assay formats is usually undertaken by pairwise concordance testing
against an established reference test. Whilst this approach is useful for
benchmarking assays in isolation, it does not always permit an under-
standing of how assays sit in the context of other similar tests. For in-
stance, although rRT-PCR is routinely chosen as the reference test, the
use of diﬀerent rRT-PCR reagents, conditions and rRT-PCR cut-oﬀ va-
lues results in variations between laboratory validation studies.
Furthermore, although these isothermal assays are regularly re-
ported as suitable for point-of-care testing (POCT) the majority of
FMDV-speciﬁc isothermal assays have been validated in laboratory
settings, using nucleic acid extracted using either robots or manual
extraction kits not suitable for ﬁeld use. A number of alternative simple
sample preparation methods have been developed: preparation of
serum, epithelial suspensions and oesophageal-pharyngeal (OP) ﬂuid
by dilution in nuclease-free water (NFW) has shown to produce accu-
rate RT-LAMP results (Waters et al., 2014; Howson et al., 2015) and
simple elution from disposable immuno-chromatographic strip tests has
been successful for sample preparation for rRT-PCR (Fowler et al.,
2014). However, these methods are yet to be compared.
In this article we present the ﬁrst comparison of diﬀerent isothermal
assay formats for detection of FMDV, using a panel of samples bench-
marked against a recommended molecular assay. Assays included re-
presentatives of RT-LAMP and RT-RPA, in addition to a selection of
sample preparation methods. These tests and sample preparation
methods were selected based on existing literature (Abd El Wahed
et al., 2013; Howson et al., 2015) and because they represent the most
realistic options for FMDV-speciﬁc POCT deployment.
2. Materials and methods
2.1. Ethics statement
All clinical samples utilised in this study were either archival sam-
ples from previous experimental studies approved by The Pirbright
Institute Ethical Review Committee under the Animal Scientiﬁc
Procedures Act (ASPA) 1986 (as amended), or comprised samples
submitted by endemic countries to The Food and Agriculture
Organization of the United Nations (FAO) World Reference Laboratory
for FMD (WRLFMD) at The Pirbright Institute (TPI), UK.
2.2. Reference real-time RT-PCR (rRT-PCR)
The one-step rRT-PCR, used as the reference test, employed primers
and probes as previously described to target the highly conserved 3Dpol-
coding region of the FMDV genome (Callahan et al., 2002). Reagents,
parameters and thermal cycling were as reported in Shaw et al. (2007).
rRT-PCR reactions were performed in duplicate on a bench top real-
time PCR machine (Stratagene Mx3005P™: Agilent Technologies, CA,
USA) (Table 1).
2.3. RT-LAMP
2.3.1. Real-time RT-LAMP (rRT-LAMP)
rRT-LAMP was performed using either Dukes et al. (2006) primers
in both wet (rRT-LAMP-D-wet) and lyophilised (rRT-LAMP-D-dry) for-
mats as previously described (Howson et al., 2015), or using primers
from Toshiba Medical Systems Corporation [TMSC] (rRT-LAMP-T-wet).
rRT-LAMP-T-wet was performed in a total reaction mixture of 25 μl,
containing: 15 μl isothermal mastermix ISO-001 (OptiGene Ltd, Hor-
sham, UK.), 2.5 μl TMSC FMDV primer mix (a proprietary RT-LAMP
primer mix targeting the 3Dpol-coding region), 0.15 U Avian Myelo-
blastosis Virus (AMV) reverse transcriptase (RT) (OptiGene Ltd.), 5 μl
sample and made up to total volume with NFW. For all rRT-LAMP
formats, reactions were performed in duplicate as previously described
(Howson et al., 2015) using a Genie® II (OptiGene Ltd.), with rRT-
LAMP-T-wet incubated at 63 °C for 30 min. Time to positivity (TP) and
anneal temperature (Ta) calculations were automated using Genie®
Explorer v0.2.1.1 software (OptiGene Ltd.). Samples were called posi-
tive if ampliﬁcation had occurred and the rRT-LAMP product annealed
in the amplicon-speciﬁc temperature range (87.5–89.5 °C for Dukes
et al. (2006) primers (Howson et al., 2015), 87.7-89.7 °C for TMSC
primers)(Table 1).
2.3.2. RT-LAMP-D combined with lateral-ﬂow detection (RT-LAMP-D-LFD)
RT-LAMP-LFD was performed using both wet (RT-LAMP-D-LFD-wet)
and lyophilised (RT-LAMP-D-LFD-dry) formats as previously described
using modiﬁed Dukes et al. (2006) LAMP primers (Waters et al., 2014;
Howson et al., 2015). Reactions were performed in duplicate on a
Table 1
Molecular assay formats compared.
Assay Method Reagents Reagent form Supplier Primers and Probes Platform
Laboratory-based rRT-PCR rRT-PCR Shaw et al., 2007 Wet Invitrogen (CA, USA) Callahan et al., 2002 Mx3005P™
rRT-LAMP-D-wet rRT-LAMP ISO–001 + AMV Wet OptiGene Ltd. Dukes et al., 2006 Genie® II
rRT-LAMP-D-dry rRT-LAMP ISO-001 (*AMV included) Lyophilised OptiGene Ltd. Dukes et al., 2006a Genie® II
RT-LAMP-LFD-D-wet rRT-LAMP-LFD ISO–001 + AMV Wet OptiGene Ltd. Dukes et al., 2006 Genie® II
RT-LAMP-LFD- D-dry rRT-LAMP-LFD ISO-001 (*AMV included) Lyophilised OptiGene Ltd. Dukes et al., 2006a Genie® II
rRT-LAMP-T-wet rRT-LAMP ISO–001 + AMV Wet OptiGene Ltd. Based on Shao et al., 2010 Genie® II
rRT-RPA-exoRT rRT-RPA TwistAmp® exo RT Lyophilised TwistDx Ltd. Abd El Wahed et al., 2013 Genie® II
rRT-RPA-nfo rRT-RPA TwistAmp® nfo+RT Lyophilised TwistDx Ltd. Abd El Wahed et al., 2013 Genie® II
a Primers, probes and Avian Myeloblastosis Virus (AMV) were lyophilised within LAMP reagents. (rRT): real-time reverse transcription; (LAMP): loop-mediated isothermal ampliﬁ-
cation using either (D) Dukes et al. (2006) or (T) Toshiba Medical Systems Corporation primers; (LFD): molecular lateral-ﬂow device; (RPA) recombinase polymerase ampliﬁcation using
either (exoRT) TwistAmp® exo RT or (nfo) TwistAmp® nfo reagents; (RT) reverse transcriptase.
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Genie® II and results were visualised using PCRD-2 lateral-ﬂow devices
(Abingdon Health, York, UK) as per manufacturer’s instructions and as
previously described (Waters et al., 2014; Howson et al., 2015). For all
images shown, the upper band represents the LFD control line (C), and
lower band the test line (T) in respect to the loading pad at the bottom
(Table 1).
2.4. Real-time RT-RPA (rRT-RPA)
2.4.1. TwistAmp® exo RT kit (rRT-RPA-exoRT)
rRT-RPA was performed using the TwistAmp® exo RT kit (TwistDx
Ltd., Cambridge, UK), with primers and probes as previously published
(Abd El Wahed et al., 2013). Reactions were performed in duplicate at
42 °C for 20 min using a Genie® II, with inversion at 5 min to mix. TP
was deﬁned when reactions reached a threshold increase of δR 1500
(Table 1).
2.4.2. TwistAmp® nfo (rRT-RPA-nfo)
the TwistAmp® nfo kit (TwistDx Ltd.) was used as manufacturer’s
instructions, with the addition of 10 U RT Transcriptor (Roche,
Mannheim, Germany). Primers and probes were as previously pub-
lished (Abd El Wahed et al., 2013). Reactions were performed in du-
plicate at 39 °C for 40 min, with inversion at 4 min to mix. TP was
calculated as above (Table 1).
2.5. Comparison in the relative performance of isothermal assays
The analytical sensitivity of reactions was determined using an ar-
tiﬁcial RNA standard. This was produced as previously described
(Howson et al., 2015) from in vitro transcription using a RT-PCR
template generated from FMDV cell culture isolate O/UKG/35/2001.
The standard (106–100 copies) was prepared in 0.1 μg/ml carrier RNA.
To determine the relative diagnostic performance of the diﬀerent
assays, RNA was extracted from a panel of clinical FMDV samples
(Table 2) that had previously been submitted to WRLFMD. These
samples comprised 35 FMDV-positive samples, representing ﬁve ser-
otypes (O, A, SAT 1, SAT 2 and Asia 1) from ten countries and eight
epithelial suspension samples representing viruses that cause similar
characteristic lesions to FMDV: swine vesicular disease virus (SVD:
UKG/24/1972; UKG/50/1972; UKG/51/1972; UKG/68/1972) and two
serotypes of vesicular stomatitis virus (VSV: Indiana 1 [VSIV] n = 2;
New Jersey [VSNJV] n = 2). RNA was extracted using a MagMAX™-96
Viral RNA Isolation Kit (Thermo Fisher Scientiﬁc, MA, USA) following
an automated procedure on a KingFisher™ Flex (Thermo Fisher Scien-
tiﬁc). RNA was extracted from 50 μl sample and eluted in a ﬁnal volume
of 90 μl MagMAX™-96 Viral RNA Isolation Kit elution buﬀer (Thermo
Fisher Scientiﬁc).
2.6. Comparison of sample preparation methodologies
To compare sample preparation methods, three decimal dilution
series (10−1 to 10−8) of FMDV (cell culture isolate O/UAE/2/2003)
were prepared in bovine epithelial suspensions (cattle tongues collected
from a UK abattoir were prepared at 10% [w/v] in M25 phosphate
buﬀer: 35 mM Na2HPO4, 5.7 mM KH2PO4, pH 7.6), bovine serum
(obtained from a UK abattoir) and bovine OP ﬂuid (archival experi-
mental samples from TPI). Aliquots were stored at−80 °C until use. All
sample preparation methods were performed on rRT-LAMP-D-wet and
rRT-RPA-exoRT, adding 5 μl of template sample to each assay.
A hierarchy of sample preparation methods were selected to
Table 2
FMDV clinical samples used for diagnostic comparison of isothermal assays.
Virus Serotype Sample Topotype Lineage Location Sample Type
FMDV O HKN/12/2015 CATHAY unnamed Hong Kong ES
IRN/26/2015 ME-SA PanAsia-2BAL−09 Iran ES
KUW/1/2016 ME-SA PanAsia-2BAL−09 Kuwait ES
KUW/4/2016 ME-SA PanAsia-2BAL−09 Kuwait ES
PAK/30/2015 ME-SA PanAsia-2BAL−09 Pakistan ES
PAK/32/2015 ME-SA PanAsia-2BAL−09 Pakistan ES
PAK/34/2015 ME-SA PanAsia-2BAL−09 Pakistan ES
PAT/4/2015 ME-SA PanAsia Palestine ES
A IRN/21/2015 ASIA G-VII Iran ES
IRN/24/2015 ASIA Iran-05SIS−10 Iran ES
SAU/8/2015 ASIA G-VII Saudi Arabia ES
PAK/31/2015 ASIA Iran-05FAR−11 Pakistan ES
PAK/56/2015 ASIA Iran-05FAR−11 Pakistan ES
TAN/15/2013 AFRICA G-I Tanzania ES
TAN/71/2012 AFRICA G-I Tanzania ES
SAT 1 TAN/22/2014 I (NWZ) unnamed Tanzania ES
TAN/29/2013 I (NWZ) – Tanzania ES
TAN/23/2013 I (NWZ) – Tanzania ES
TAN/50/2012 I (NWZ) unnamed Tanzania ES
KEN/26/2008 I (NWZ) – Kenya ES
KEN/9/2009 I (NWZ) – Kenya ES
KEN/12/2009 I (NWZ) – Kenya ES
SAT 2 ZIM/9/2015 II unnamed Zimbabwe ES
ZIM/21/2015 II unnamed Zimbabwe ES
TAN/3/2011 IV IV Tanzania ES
TAN/64/2012 IV unnamed Tanzania ES
TAN/14/2012 IV unnamed Tanzania ES
TAN/19/2012 IV unnamed Tanzania ES
KEN/2/2007 IV – Kenya ES
SUD/7/2014 VII Alx-12 Sudan ES
Asia 1 IRN/20/2015 ASIA Sindh-08 Iran ES
PAK/33/2015 ASIA Sindh-08 Pakistan ES
PAK/28/2015 ASIA Sindh-08 Pakistan OF
PAK/29/2015 ASIA Sindh-08 Pakistan OF
PAK/43/2015 ASIA Sindh-08 Pakistan ES
(FMDV): foot-and-mouth disease virus; ES (epithelial suspension); OF (oral ﬂuid).
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compare, ranging from sophisticated laboratory nucleic extraction
methods to simpler methods such as dilution of samples in NFW. Three
nucleic extraction methods were tested. The MagMAX™-96 Viral RNA
Isolation Kit was used as the reference sample procedure (MagMAX™-96
Viral RNA Isolation Kit/KingFisher™ Flex system as described above).
The kit was also evaluated using a manual protocol, following manu-
facturer’s manual guidelines with a DynaMag™- Spin magnet (Thermo
Fisher Scientiﬁc). The third extraction method evaluated was the
QIAamp® Viral RNA Mini Kit (Qiagen, Hilden, Germany), which was
used according to manufacturer’s guidelines. RNA was extracted from
140 μl of sample (using the spin column protocol) and eluted in a ﬁnal
volume of 60 μl in QIAamp® buﬀer AVE (Qiagen).
In addition, a number of simple sample preparation methods were
selected as they had been previously described as simple techniques for
PCR inhibitor removal (Walsh et al., 1991; Ochert et al., 1994; Wu and
Kado, 2004; Fowler et al., 2014; Waters et al., 2014; Howson et al.,
2015). The simplest of techniques tested was the dilution of samples 1
in 5, 1 in 10 or 1 in 20 in NFW. Secondly, syringe ﬁlters were evaluated
by diluting samples 1 in 5 in NFW and passing 1 ml of sample through a
Acrodisc® 25 mm syringe ﬁlter (w/0.1 um Supor® Membrane) (Pall Life
Sciences, MI, USA). Thirdly, Chelex® 100 was evaluated by adding 50 μl
of 50% (w/v) Chelex® 100–500 μl of diluted sample (1 in 5 in NFW).
Samples were vortexed, allowed to settle and the supernatant used in
assays. For Chelex® 100 (heat), samples were heated at 56 °C for 10 min
prior to processing as previously stated. Finally, extraction from an-
tigen-detection lateral-ﬂow devices (Ag-LFDs) was evaluated (epithelial
material only), by adding 200 μl of each suspension to SVANODIP®
FMDV-Ag-LFDs (Ferris et al., 2009; Boehringer Ingelheim, Bracknell,
UK) and incubating at room temperature (25 °C) for 72 h. Nucleic acid
was extracted from the loading pad and wicking strip of the Ag-LFDs as
previously described (Fowler et al., 2014).
3. Results
3.1. Comparison in the performance of isothermal assays
The analytical sensitivities of rRT-PCR, RT-LAMP (all formats) and
rRT-RPA-exoRT, using the RNA standard, were 101, 101, and 102 co-
pies/μl, respectively (Fig. 1). Two log10 reductions in analytical sensi-
tivity was evident for rRT-RPA-nfo compared to rRT-PCR, detecting
down to 103 copies/μl (Fig. 1).
For diagnostic performance, the concordance between each iso-
thermal assay and rRT-PCR for clinical samples (n = 43) were as fol-
lows: rRT-LAMP-D-wet (38/43 [88%]), rRT-LAMP-D-dry (38/43
[88%]), RT-LAMP-LFD-D-wet (37/43 [86%]), RT-LAMP-LFD-D-dry (37/
43 [86%]), rRT-LAMP-T-wet (42/43 [98%]), rRT-RPA-exoRT (33/43
[77%]) and rRT-RPA-nfo (29/43 [67%]); false negative samples con-
sistently had high rRT-PCR CT values (Fig. 2) with no false positives
detected for any test. All assays yielded negative results against SVDV
and VSV isolates (data not shown).
3.2. Comparison of sample preparation methodologies
Nine simple methods were compared for preparation of samples
prior to molecular analysis, using the MagMAX™-96 Viral RNA Isolation
Kit/KingFisher™ Flex system as the reference sample preparation pro-
cedure. For both rRT-LAMP-D-wet and rRT-RPA-exoRT, the use of
simple extraction kits (QIAamp® and MagMAX™-96 Viral RNA Isolation
Fig. 1. Analytical sensitivity of seven isothermal assay formats using a RNA standard. Results were compared to the diagnostic laboratory-based real-time reverse transcription (rRT)-PCR
(▼). ● rRT-loop-mediated isothermal ampliﬁcation using Dukes et al. (2006) primers (rRT-LAMP-D)-wet; ○rRT-LAMP-D-dry; ■ rRT-recombinase polymerase ampliﬁcation (RPA)-
exoRT; □rRT-RPA-nfo;▲ rRT-LAMP using Toshiba primers (rRT-LAMP-T)-wet. Half shaded points represent samples where one duplicate was positive and the other negative; grey
shaded points (for rRT-PCR) represent CT values that were over the diagnostic cut-oﬀ value of CT<32 (Shaw et al., 2007). For the molecular lateral-ﬂow devices (LFD), the presence of a
test (T) and control (C) line signiﬁes a positive result; the presence of a single control band signiﬁes a negative result (C). For all assays, both duplicates had to be positive for the sample to
be regarded as a positive.
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Kit [manual]) achieved comparable analytical sensitivity across all
sample types to the reference sample preparation procedure (Figs. 3A
[epithelium], 3D [serum], 3G [OP ﬂuid] and 4A [epithelium], 4D
[serum], 4G [OP ﬂuid]). For rRT-LAMP-D-wet, the direct use of epi-
thelial samples (1 in 5, 1 in 10 or 1 in 20 dilution in NFW) resulted in a
one log10 reduction in limit of detection (LOD) compared to the use of
extraction kits (Fig. 3B). When epithelial samples were eluted from Ag-
LFDs (which were positive up to 10−3 of the dilution series) or sub-
jected to either Chelex® 100 treatment or syringe ﬁltering (after 1 in 5
dilution in NFW), a further decrease in LOD was observed (Fig. 3C). A
one log10 reduction was also evident for rRT-RPA-exoRT when using
epithelial samples directly (using dilution in NFW) (Fig. 4B) compared
to extracted RNA (Fig. 4A), however non-speciﬁc ampliﬁcation was
evident in negative samples; this was removed by pre-processing of 1 in
5 dilutions through a syringe ﬁlter (Fig. 4C).
For serum, a two log10 reduction in LOD was evident when serum
was diluted prior to analysis in rRT-LAMP-D-wet (Fig. 3E) compared to
the use of extracted RNA (Fig. 3D). When serum was added neat to
reactions rRT-LAMP-D-wet was inhibited (Fig. 3E). Following 1 in 5
dilution of serum in NFW, the use of Chelex® 100 (heat) improved LOD,
with only a one log10 reduction in LOD evident compared to the use of
extracted RNA (Fig. 3F). For rRT-RPA-exoRT, the use of simple sample
preparation techniques for serum resulted in assay inhibition (Fig. 4E
and 4F), with extraction required (using any of the three RNA extrac-
tion methods tested) in order for ampliﬁcation to be observed (Fig. 4D).
For OP ﬂuid, again a two log10 reduction in LOD for rRT-LAMP-D-
wet was evident when OP ﬂuid was diluted in NFW (1 in 10 or 1 in 20)
prior to analysis (Fig. 3H), compared to the use of extracted RNA
(Fig. 3G). Neat OP ﬂuid and OP ﬂuid samples diluted 1 in 5 (with or
without Chelex® 100 treatment or syringe ﬁltering), reduced the ana-
lytical sensitivity of rRT-LAMP-D-wet (Fig. 3H and 3I), with a three
log10 reduction in LOD evident compared to the use of extracted RNA.
For rRT-RPA-exoRT, extraction of RNA from OP ﬂuid was required
(Fig. 4G), with the use of simple sample preparation methods (either
neat, using dilutions [with or without Chelex® 100 or syringe ﬁlter
treatment]) resulting in assay inhibition (Fig. 4H and I).
4. Discussion
The requirement for rapid and accurate diagnosis of FMD has led to
Fig. 2. Concordance between the diagnostic laboratory-based real-time reverse transcription (rRT)-PCR and isothermal assays using 43 clinical samples: rRT-loop-mediated isothermal
ampliﬁcation using Dukes et al. (2006) primes (rRT-LAMP-D)-wet (A), rRT-LAMP using Toshiba primers (rRT-LAMP-T)-wet (B), rRT-recombinase polymerase ampliﬁcation (RPA)-exoRT
(C) and rRT-RPA-nfo (D). Grey box highlights rRT-PCR CT values over the diagnostic threshold of CT<32 (Shaw et al., 2007). Lyophilisation of rRT-LAMP-D did not impact assay
performance.
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an increased interest in evaluating simple-to-use diagnostic platforms
that can be deployed closer to suspect cases of FMD. For instance, ﬁeld-
ready rRT-PCR, rRT-LAMP, RT-LAMP-LFD and rRT-RPA have been
successfully trialled in endemic settings, allowing for accurate detection
of FMDV in situ (Abd El Wahed et al., 2013; Howson et al., 2015).
However, based on the lack of formal comparisons between these dif-
ferent assays, in addition to the lack of standardisation in assay eva-
luation, it is diﬃcult to accurately gauge the best isothermal test based
on independent publications at present. This manuscript details a
comparison of multiple isothermal chemistries, assay formats and
sample preparation procedures for detection of FMDV.
The analytical sensitivities of isothermal assays were equivalent to
previously published results when using an FMDV RNA standard, with
all RT-LAMP assay formats showing comparable analytical sensitivity to
rRT-PCR (Waters et al., 2014; Howson et al., 2015) and rRT-RPA-exoRT
displaying a one log10 reduction in sensitivity (Abd El Wahed et al.,
2013). However in this study, the template of choice impacted upon
assay performance with more variation evident between assays when
assessing relative diagnostic sensitivity using RNA extracted from
clinical samples. This is likely due to the absence of host-derived nu-
cleic acid and/or absence of nucleic acid structures present in a RNA
standards, however further work is required to conﬁrm this. These re-
sults should be considered by researchers when evaluating new assays,
to prevent the false overestimation of sensitivity and performance if this
is determined using a RNA standard only.
Consistent with Yamazaki et al. (2013) who evaluated Shao et al.
(2010) primers and probes (TMSC primers are based on these), rRT-
LAMP-T-wet displayed the highest sensitivity of all isothermal assays,
however at present this assay has only been evaluated in a wet format
suitable for laboratory settings. As previously published by Howson
et al. (2015), lyophilisation of rRT-LAMP-D and RT-LAMP-LFD-D re-
agents did not impact on the assay sensitivity or speciﬁcity; similar
work needs to be carried out for rRT-LAMP-T-wet to transition this
assay into a format suitable for ﬁeld use. For rRT-RPA, the TwistAmp®
exo RT kit displayed better performance than the TwistAmp® nfo kit,
likely due to the addition of Exonuclease III, which contains 3ʹ-5ʹ
Fig. 3. Comparison of sample preparation methods for real-time reverse transcription loop-mediated isothermal ampliﬁcation using Dukes et al. (2006) primers (rRT-LAMP-D-wet). The
top row (A-C) presents results for epithelial suspensions; the middle for serum samples (D-F); the bottom for oesophageal-pharyngeal (OP) ﬂuid (G-I). A total of 11 sample preparation
methods were trialled: (A,D,G): RNA extraction methods; (B,E,H): use of neat samples or dilution in nuclease-free water; (C,F,I): 1 in 5 dilutions subjected to further treatment using
Chelex® or syringe ﬁltering. (Extraction from antigen-detection lateral-ﬂow devices [Ag-LFD] was trialled for neat epithelial suspensions only) Half shaded points represent samples where
one duplicate was positive and the other negative; both duplicates had to be positive for the sample to be regarded as a positive.
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exonuclease activity, enhancing ﬂuorescent probe degradation during
ampliﬁcation. However, rRT-RPA assays consistently had reduced
sensitivity compared to all RT-LAMP formats; previous studies have
shown that the additional RT enzyme (RT ‘Transcriptor’, Roche) to the
TwistAmp® exo RT kit helped to increase assay sensitivity (Abd El
Wahed et al., 2013), however this requires maintenance of the cold
chain and is consequently less suitable for ﬁeld-based assays.
Sample preparation remains the bottleneck of in situ nucleic acid
detection, with current procedures being complex, time-consuming and
requiring both dedicated laboratory spaces and specialised equipment
(Dineva et al., 2007). This manuscript also presents a comparison of
diﬀerent simple sample preparation techniques across two isothermal
assays. For both rRT-LAMP-D-wet and rRT-RPA-exoRT, both manual
nucleic extraction kits gave comparable analytical sensitivity to auto-
mated extraction across all sample types. However, the requirement for
multiple stages limits the use of these to laboratory settings, with more
direct procedures required for ﬁeld-based detection of FMDV.
rRT-RPA-exoRT displayed poor tolerance to inhibitors, with both
sera and OP ﬂuid inhibiting assays when added in the absence of RNA
extraction. For epithelial suspensions, ampliﬁcation in the rRT-RPA-
exoRT assay was evident following dilution of the samples, however
syringe ﬁlters were required to prevent non-speciﬁc ampliﬁcation.
Previous studies have indicated that LAMP shows increased tolerance to
inhibitors compared to PCR (Poon et al., 2006; Waters et al., 2014). In
this study, rRT-LAMP was performed in the absence of RNA extraction
for multiple sample types (epithelial suspensions, sera and OP ﬂuid).
However, the analytical sensitivity of rRT-LAMP reactions was reduced
when using simple sample preparation methods compared to RNA ex-
traction. For instance, simple dilution of epithelial suspensions in NFW
(1 in 5, 1 in 10 or 1 in 20) resulted in an one log10 decrease in sensi-
tivity, consistent with the dilution factor. For serum, the use of Chelex®
100 (plus a heat stage) produced the best results for direct rRT-LAMP-D-
wet, with a one log10 decrease in sensitivity compared to extraction
methods (again consistent with dilution factor and previous
Fig. 4. Comparison of sample preparation methods for real-time reverse transcription recombinase polymerase ampliﬁcation using TwistAmp® exo RT kit (rRT-RPA-exoRT). Sample
preparation methods were trialled across three sample types: epithelial suspensions (A-C), serum samples (D-F) and oesophageal-pharyngeal (OP) ﬂuid (G-I). Eleven sample preparation
methods were tested: (A,D,G): RNA extraction methods; (B,E,H): use of neat samples or dilution in nuclease-free water; (C,F,I): 1 in 5 dilutions subjected to Chelex® or syringe ﬁltering
(antigen-detection lateral-ﬂow devices [Ag-LFD] extraction was trialled for neat epithelial suspensions only). NS: non-speciﬁc ampliﬁcation detected (signiﬁed by ampliﬁcation present in
known negative samples); AI: assay inhibition. Half shaded points represent samples where one duplicate was positive and the other negative; both duplicates had to be positive for the
sample to be regarded as a positive.
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publications (Howson et al., 2015)). Chelex® 100 has previously been
reported as an extraction method for serum, as the ion-exchange resin
removes the eﬀect of inhibitors (Walsh et al., 1991; Ochert et al., 1994);
the same eﬀect was not seen for the other sample types. Direct sample
preparation methods for OP ﬂuid resulted in a two log10 decrease in the
rRT-LAMP-D-wet assay LOD compared to extraction methods, sug-
gesting partial assay inhibition in addition to the eﬀects of dilution
factor, consistent with previous publications (Howson et al., 2015).
Although the evaluation of assay performance is speciﬁc to the
conditions/primers tested in this analysis, the compatibility of RT-
LAMP chemistry with numerous sample types oﬀers advantages over
current point of care tests by being able to detect FMDV across a larger
diagnostic window of detection, in addition to displaying increased
analytical sensitivity. For example, Ag-LFDs only oﬀer equivalent di-
agnostic sensitivity to laboratory-based Ag-ELISAs (Ferris et al., 2009),
which limits their application to the acute clinical phase of disease and
samples which contain high amounts of intact virus particles (epithe-
lium and vesicular ﬂuid only).
5. Conclusions
In conclusion, this manuscript presents the ﬁrst side-by-side analysis
of multiple isothermal assay formats in order to deﬁne their current
capabilities benchmarked against rRT-PCR. RT-LAMP assays are com-
parable to the diagnostic rRT-PCR when considering a cut-oﬀ value and
using extraction methods. Signiﬁcantly, for RT-LAMP there was only a
one log10 reduction in sensitivity when RNA extraction was negated for
epithelial tissue suspensions (diluted 1 in 5) and serum samples (treated
with Chelex® 100 [heat]). RT-RPA was not as sensitive as rRT-PCR
(using RNA extraction), and when used in the absence of extraction
techniques was prone to inhibition across OP ﬂuid and serum samples.
With standard extraction techniques not a viable option for pen-side
testing, the ability to perform RT-LAMP in the absence of RNA ex-
traction over a large diagnostic detection window, provides a realistic
means to rapidly conﬁrm positive FMD cases close to the point of
sampling.
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